Jackson Acquisition Co II

Análisis de la acción Jackson Acquisition Co II (JACS)

$10.750

+0.010 (+0.09%)Al cierre

Loading chart…
High
10.750
Open
10.750
VWAP
10.75
Vol
356.87K
Mkt Cap
Low
10.750
Amount
3.84M
EV/EBITDA, TTM
0.00

Jackson Acquisition Company II is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. It may pursue an initial business combination target in any industry or geographic location, it intends to focus its search for a target business by concentrating its efforts in identifying businesses with a focus on healthcare services, healthcare technology, or otherwise focused on the healthcare industry. The Company neither engaged in any operations nor generated any revenue.

AI analysis of Jackson Acquisition Co II (JACS)

hold

Currently, Jackson Acquisition Company II (JACS) is trading at $10.74 with a 1-year change of +3.77%. The RSI is at 61.973, indicating that the stock is nearing overbought territory, which could limit upside potential in the short term. The forward P/E ratio is 0, suggesting that earnings expectations are not currently priced into the stock, which could indicate uncertainty about future profitability. However, the stock has shown a positive trend with a 5-day change of +0.09% and a year-to-date change of +3.07%. The main risk is the low current ratio of 0.77, indicating potential liquidity issues. Overall, while there are some positive indicators, the lack of significant momentum and potential liquidity concerns suggest holding rather than buying at this time.

Métricas de valoración

The current forward P/E ratio for Jackson Acquisition Co II (JACS) is 0.00, compared to its 5-year average forward P/E of 0.00.

Forward P/E

Strongly Undervalued
5Y Average P/E
0.00
Current P/E
0.00
Sobrevalorada
0.00
Infravalorada
0.00

Forward EV/EBITDA

Strongly Undervalued
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Sobrevalorada
0.00
Infravalorada
0.00

Forward P/S

Fair
5Y Average P/S
0.12
Current P/S
0.00
Sobrevalorada
1.23
Infravalorada
-0.99

Alphio AI Price Scenarios for JACS

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%JACS

$14.19

Precio del escenario

B

Base

Base · 50%JACS

$12.49

Precio del escenario

B

Bear

Bear · 25%JACS

$10.64

Precio del escenario

Whales holding JACS

G

Glazer Capital, LLC

+ HoldingJACS

-0.01%

3M Return

JACS FAQ — answered by Alphio AI

Jackson Acquisition Company II is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. It may pursue an initial business combination target in any industry or geographic location, it intends to focus its search for a target business by concentrating its efforts in identifying businesses with a focus on healthcare services, healthcare technology, or otherwise focused on the healthcare industry. The Company neither engaged in any operations nor generated any revenue. It operates in the Financials sector.

Currently, Jackson Acquisition Company II (JACS) is trading at $10.74 with a 1-year change of +3.77%. The RSI is at 61.973, indicating that the stock is nearing overbought territory, which could limit upside potential in the short term. The forward P/E ratio is 0, suggesting that earnings expectations are not currently priced into the stock, which could indicate uncertainty about future profitability. However, the stock has shown a positive trend with a 5-day change of +0.09% and a year-to-date change of +3.07%. The main risk is the low current ratio of 0.77, indicating potential liquidity issues. Overall, while there are some positive indicators, the lack of significant momentum and potential liquidity concerns suggest holding rather than buying at this time.

Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.

Empieza gratis